C9H10N2O5 6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidin-6-one, 2,3,3a,9a-tetrah ydro-3-hydroxy-2-(hydroxymethyl)-, (2R,3 R,3aS,9aR)- (9CI, ACI)

Souri kanonyal
O = C1N = C2OC3C (O) C (OC3N2C = C1) CO
Souri izomèr
O [C@H] 1 [C@] 2 ([C@] (N3C (O2) = NC (= O) C = C3) (O [C @@ H] 1CO) [H]) [H]
Inchi
Inchi = 1S/C9H10N2O5/C12-3-4-6 (14) 7-8 (15-4) 11-2-1-5 (13) 10-9 (11) 16-7/h1-2,4,6-8,12,14H, 3H2/T4-, 6-, 7+, 8-/m1/s1
Inchi kle
Uugitdaswnoagg-ccxzuqqusa-n
13 Lòt non pou sibstans sa a
(2r, 3 r, 3as, 9ar) -2,3,3a, 9a-tetrahydro-3-hydroxy-2- (hydroxymethyl) -6h-furo [2 ′, 3 ′: 4,5] oxazolo [3,2-a] pirimidin-6-one (ACI); 6H-furo [2 ′, 3 ′: 4,5] oxazolo [3,2-A] pirimidin-6-yon sèl, 2,3,3a, 9a-tetrahydro-3-hydroxy-2- (idroksimetil)-(6ci, 7ci); 6H-furo [2 ′, 3 ′: 4,5] oxazolo [3,2-A] pirimidin-6-yon sèl, 2,3,3a, 9a-tetrahydro-3-hydroxy-2- (hydroxymethyl)-, [2R- (2α, 3β, 3aβ, 9aβ))]; 6h-furo [2 ′, 3 ′: 4,5] oxazolo [3,2-A]

Pyrimidin-6-yon sèl, 2,3,3a, 9a-tetrahydro-3-hydroxy-2- (hydroxymethyl)-, stereoisomer (8ci); 2,2 ′ -anhydro (1- β -D -arabinofuranosyl) uracil; 2,2 ′ -anhydro-1- β-D-arabino-furanosyluracil; 2,2 ′ -anhydro-N1- (β-D-arabinofuranosyl) uracil; 2,2 ′ -anhydrouridine; 2,2 ′ -o -cyclouridine; NSC 157148; O2,2 ′ -Anhydrouridine; O2,2 ′ -cyclouridine; β-D-2 ′, 2-O-cycloarabinouridine